Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$130.73 +0.32 (+0.25%)
(As of 12/17/2024 ET)

ADUS vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, LFST, SGRY, CON, and PRVA

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), LifeStance Health Group (LFST), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

Addus HomeCare vs.

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, media sentiment, community ranking, earnings, institutional ownership, profitability, risk, dividends and analyst recommendations.

Hims & Hers Health has a net margin of 8.19% compared to Addus HomeCare's net margin of 6.50%. Hims & Hers Health's return on equity of 10.97% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Addus HomeCare 6.50%9.62%7.37%

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 4.6% of Addus HomeCare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Hims & Hers Health had 12 more articles in the media than Addus HomeCare. MarketBeat recorded 25 mentions for Hims & Hers Health and 13 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.92 beat Hims & Hers Health's score of 0.41 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
9 Very Positive mention(s)
4 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
5 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Addus HomeCare has lower revenue, but higher earnings than Hims & Hers Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.24B5.47-$23.55M$0.4470.73
Addus HomeCare$1.13B2.09$62.52M$4.3729.92

Addus HomeCare received 285 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.79% of users gave Addus HomeCare an outperform vote while only 38.61% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
39
38.61%
Underperform Votes
62
61.39%
Addus HomeCareOutperform Votes
324
68.79%
Underperform Votes
147
31.21%

Hims & Hers Health presently has a consensus price target of $22.80, indicating a potential downside of 26.74%. Addus HomeCare has a consensus price target of $133.67, indicating a potential upside of 2.25%. Given Addus HomeCare's stronger consensus rating and higher possible upside, analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.41
Addus HomeCare
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.90

Hims & Hers Health has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.

Summary

Hims & Hers Health and Addus HomeCare tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.37B$2.87B$5.14B$9.31B
Dividend YieldN/A0.36%4.81%4.06%
P/E Ratio29.9227.50135.1817.53
Price / Sales2.091.131,235.42140.39
Price / Cash23.9616.4940.6537.95
Price / Book3.003.214.884.92
Net Income$62.52M-$57.02M$118.97M$225.78M
7 Day Performance8.13%-0.59%16.19%-1.58%
1 Month Performance10.54%1.50%16.02%6.67%
1 Year Performance38.43%15.38%34.95%22.48%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.7566 of 5 stars
$130.73
+0.2%
$133.67
+2.2%
+40.9%$2.37B$1.13B29.9234,846Analyst Forecast
Short Interest ↓
High Trading Volume
HIMS
Hims & Hers Health
3.4624 of 5 stars
$33.73
-1.5%
$21.43
-36.5%
+268.3%$7.37B$872M75.051,046Analyst Forecast
Insider Trade
Short Interest ↑
Gap Up
GH
Guardant Health
3.8127 of 5 stars
$36.68
-0.5%
$40.60
+10.7%
+23.6%$4.53B$692.26M-8.561,779
OPCH
Option Care Health
4.8556 of 5 stars
$23.07
+1.0%
$30.14
+30.7%
-26.7%$3.93B$4.30B19.207,802Positive News
SHC
Sotera Health
3.83 of 5 stars
$13.43
+2.3%
$16.08
+19.8%
-17.3%$3.80B$1.05B53.923,000News Coverage
Positive News
VCYT
Veracyte
4.178 of 5 stars
$42.24
-4.3%
$41.13
-2.6%
+49.9%$3.27B$361.05M0.00790Positive News
BTSG
BrightSpring Health Services
2.3984 of 5 stars
$17.98
-1.6%
$17.21
-4.3%
N/A$3.13B$8.83B0.0035,000Analyst Forecast
LFST
LifeStance Health Group
2.0521 of 5 stars
$7.51
+2.3%
$8.50
+13.2%
+2.9%$2.87B$1.06B0.009,325Analyst Upgrade
News Coverage
Positive News
Gap Up
SGRY
Surgery Partners
3.564 of 5 stars
$22.11
+1.0%
$37.38
+69.0%
-35.2%$2.81B$2.74B0.0013,500Analyst Forecast
CON
Concentra Group Holdings Parent
N/A$20.50
+1.1%
$28.50
+39.0%
N/A$2.61B$1.84B0.0011,000Analyst Upgrade
Gap Up
PRVA
Privia Health Group
3.2148 of 5 stars
$21.45
+1.3%
$24.79
+15.6%
-7.8%$2.57B$1.66B211.821,102Analyst Forecast
News Coverage

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners